Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells

Kang Fang, Shih Ping Chen, Chia Wei Lin, Wan Chun Cheng, Hwei Tien Huang

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Ellipticine and its analogues were reported as topoisomerase II inhibitors and promising antitumor agents. In this work, we showed that the growth of human non-small-cell-lung-cancer (NSCLC) epithelial cells A549 can be inhibited by ellipticine. The inhibitory effect was reverted by PI3K inhibitors. The sub-G 1 phase cells after ellipticine treatment appeared at the expense of those that accumulated first at S- and G 2 /M phases during the early stage of treatment. We showed that the progression leading to cell death was impaired by wortmannin, which reverted apoptosis by retaining cells at S- and G 2 /M transition states. The characteristic apoptosis marker p53 activation after treatment appeared first followed by poly(ADP-ribose)polymerase (PARP) fragmentation. They disappeared upon co-treatment with wortmannin and the apoptotic phenotype reversed. Furthermore, ellipticine regulated endogenous survival signaling by up-regulating phosphorylated Akt that returned to its basal level later. Furthermore, ellipticine induced nucleus translocalization of p53 and Akt and recruitment of autophagosomes. The autophagic-related cell death was interfered by wortmannin and the suppressed growth reverted. The Akt-related cell death also occurred in p53-deficient cells with stable expression of exogenous p53. The work showed that ellipticine-induced cytotoxicity in NSCLC cells was achieved through autophagy and apoptotic death as a result of Akt-modulation. Being a topoisomerase II inhibitor, ellipticine proved a regulator in autophagy-related cell death through corporation of p53 and Akt.

Original languageEnglish
Pages (from-to)227-234
Number of pages8
JournalLung Cancer
Volume63
Issue number2
DOIs
Publication statusPublished - 2009 Feb

Fingerprint

ellipticine
Lung Neoplasms
Epithelial Cells
Apoptosis
Autophagy
Topoisomerase II Inhibitors
Cell Death
Non-Small Cell Lung Carcinoma
Poly(ADP-ribose) Polymerases
Growth
Phosphatidylinositol 3-Kinases
Cell Division
Antineoplastic Agents

Keywords

  • Akt
  • Apoptosis
  • Ellipticine
  • Human non-small-cell-lung-cancer cells

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells. / Fang, Kang; Chen, Shih Ping; Lin, Chia Wei; Cheng, Wan Chun; Huang, Hwei Tien.

In: Lung Cancer, Vol. 63, No. 2, 02.2009, p. 227-234.

Research output: Contribution to journalArticle

Fang, Kang ; Chen, Shih Ping ; Lin, Chia Wei ; Cheng, Wan Chun ; Huang, Hwei Tien. / Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells. In: Lung Cancer. 2009 ; Vol. 63, No. 2. pp. 227-234.
@article{a8e3da445c89438cb6923c6ff27181fc,
title = "Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells",
abstract = "Ellipticine and its analogues were reported as topoisomerase II inhibitors and promising antitumor agents. In this work, we showed that the growth of human non-small-cell-lung-cancer (NSCLC) epithelial cells A549 can be inhibited by ellipticine. The inhibitory effect was reverted by PI3K inhibitors. The sub-G 1 phase cells after ellipticine treatment appeared at the expense of those that accumulated first at S- and G 2 /M phases during the early stage of treatment. We showed that the progression leading to cell death was impaired by wortmannin, which reverted apoptosis by retaining cells at S- and G 2 /M transition states. The characteristic apoptosis marker p53 activation after treatment appeared first followed by poly(ADP-ribose)polymerase (PARP) fragmentation. They disappeared upon co-treatment with wortmannin and the apoptotic phenotype reversed. Furthermore, ellipticine regulated endogenous survival signaling by up-regulating phosphorylated Akt that returned to its basal level later. Furthermore, ellipticine induced nucleus translocalization of p53 and Akt and recruitment of autophagosomes. The autophagic-related cell death was interfered by wortmannin and the suppressed growth reverted. The Akt-related cell death also occurred in p53-deficient cells with stable expression of exogenous p53. The work showed that ellipticine-induced cytotoxicity in NSCLC cells was achieved through autophagy and apoptotic death as a result of Akt-modulation. Being a topoisomerase II inhibitor, ellipticine proved a regulator in autophagy-related cell death through corporation of p53 and Akt.",
keywords = "Akt, Apoptosis, Ellipticine, Human non-small-cell-lung-cancer cells",
author = "Kang Fang and Chen, {Shih Ping} and Lin, {Chia Wei} and Cheng, {Wan Chun} and Huang, {Hwei Tien}",
year = "2009",
month = "2",
doi = "10.1016/j.lungcan.2008.05.026",
language = "English",
volume = "63",
pages = "227--234",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells

AU - Fang, Kang

AU - Chen, Shih Ping

AU - Lin, Chia Wei

AU - Cheng, Wan Chun

AU - Huang, Hwei Tien

PY - 2009/2

Y1 - 2009/2

N2 - Ellipticine and its analogues were reported as topoisomerase II inhibitors and promising antitumor agents. In this work, we showed that the growth of human non-small-cell-lung-cancer (NSCLC) epithelial cells A549 can be inhibited by ellipticine. The inhibitory effect was reverted by PI3K inhibitors. The sub-G 1 phase cells after ellipticine treatment appeared at the expense of those that accumulated first at S- and G 2 /M phases during the early stage of treatment. We showed that the progression leading to cell death was impaired by wortmannin, which reverted apoptosis by retaining cells at S- and G 2 /M transition states. The characteristic apoptosis marker p53 activation after treatment appeared first followed by poly(ADP-ribose)polymerase (PARP) fragmentation. They disappeared upon co-treatment with wortmannin and the apoptotic phenotype reversed. Furthermore, ellipticine regulated endogenous survival signaling by up-regulating phosphorylated Akt that returned to its basal level later. Furthermore, ellipticine induced nucleus translocalization of p53 and Akt and recruitment of autophagosomes. The autophagic-related cell death was interfered by wortmannin and the suppressed growth reverted. The Akt-related cell death also occurred in p53-deficient cells with stable expression of exogenous p53. The work showed that ellipticine-induced cytotoxicity in NSCLC cells was achieved through autophagy and apoptotic death as a result of Akt-modulation. Being a topoisomerase II inhibitor, ellipticine proved a regulator in autophagy-related cell death through corporation of p53 and Akt.

AB - Ellipticine and its analogues were reported as topoisomerase II inhibitors and promising antitumor agents. In this work, we showed that the growth of human non-small-cell-lung-cancer (NSCLC) epithelial cells A549 can be inhibited by ellipticine. The inhibitory effect was reverted by PI3K inhibitors. The sub-G 1 phase cells after ellipticine treatment appeared at the expense of those that accumulated first at S- and G 2 /M phases during the early stage of treatment. We showed that the progression leading to cell death was impaired by wortmannin, which reverted apoptosis by retaining cells at S- and G 2 /M transition states. The characteristic apoptosis marker p53 activation after treatment appeared first followed by poly(ADP-ribose)polymerase (PARP) fragmentation. They disappeared upon co-treatment with wortmannin and the apoptotic phenotype reversed. Furthermore, ellipticine regulated endogenous survival signaling by up-regulating phosphorylated Akt that returned to its basal level later. Furthermore, ellipticine induced nucleus translocalization of p53 and Akt and recruitment of autophagosomes. The autophagic-related cell death was interfered by wortmannin and the suppressed growth reverted. The Akt-related cell death also occurred in p53-deficient cells with stable expression of exogenous p53. The work showed that ellipticine-induced cytotoxicity in NSCLC cells was achieved through autophagy and apoptotic death as a result of Akt-modulation. Being a topoisomerase II inhibitor, ellipticine proved a regulator in autophagy-related cell death through corporation of p53 and Akt.

KW - Akt

KW - Apoptosis

KW - Ellipticine

KW - Human non-small-cell-lung-cancer cells

UR - http://www.scopus.com/inward/record.url?scp=58049195157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58049195157&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2008.05.026

DO - 10.1016/j.lungcan.2008.05.026

M3 - Article

C2 - 18619705

AN - SCOPUS:58049195157

VL - 63

SP - 227

EP - 234

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -